Compare Eli Lilly And Co (LLY) vs First Trust Cloud Computing ETF (SKYY) Price & Performance

Eli Lilly (LLY) trades at $1,150.86, down 2.39% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $8.55 exceeding expectations by 23%. Revenue surged to $65.18 billion in 2025, driving a net income margin of 34.99%. Recent news highlights LLY's $2.8 billion acquisition of AtaiBeckley to expand its neuroscience pipeline, signaling strategic growth in mental health treatments.

Outlook remains positive with analyst consensus price target of $1,380 implying 20% upside, supported by 73% buy ratings. Key risks include high valuation multiples (P/E 41.89) and rising debt levels, though operating cash flow growth to $16.81 billion in 2025 provides financial flexibility. Investors should monitor Q2 2026 earnings on August 5 for continued execution on weight-loss drug demand and integration of recent acquisitions.

First Trust Cloud Computing ETF (SKYY) trades at $136.66, up 0.41% with a bullish technical signal from moving averages. The ETF provides diversified exposure to cloud computing companies amid strong sector inflows driven by enterprise AI adoption. Recent news highlights continued institutional interest in technology ETFs, with SKYY positioned as a core holding for cloud computing exposure.

The outlook remains positive as cloud computing benefits from enterprise digital transformation and AI spending acceleration. Key risks include technology sector volatility and competitive pressures from alternative cloud ETFs. Analyst coverage emphasizes SKYY's established track record since 2011 launch and broad market positioning.